Therefore, in effort to increase the anti-tumor efficacy of PD-1/PD-L1 immune checkpoint blockade, we investigated the in vivo effects of PRI-724 treatment in combination with an anti-PD-L1 Ab on the progression of liver metastasis from colon cancer using an mouse model. This evidence concerns the gene CD274 and malignant colon neoplasm.